Provided by Tiger Trade Technology Pte. Ltd.

Spruce Biosciences, Inc.

89.20
+6.097.33%
Post-market: 88.50-0.7000-0.78%18:34 EST
Volume:108.68K
Turnover:9.62M
Market Cap:95.06M
PE:-1.05
High:92.42
Open:87.57
Low:83.12
Close:83.11
52wk High:240.00
52wk Low:4.28
Shares:1.07M
Float Shares:877.30K
Volume Ratio:0.63
T/O Rate:12.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-84.7510
EPS(LYR):-96.3944
ROE:-167.93%
ROA:-76.92%
PB:17.65
PE(LYR):-0.93

Loading ...

Top News Today: Stocks Mixed as AI Selloff Slows

Dow Jones
·
Nov 15

Spruce Biosciences Is Maintained at Market Outperform by Citizens

Dow Jones
·
Nov 11

Spruce Biosciences price target raised to $259 from $254 at Citizens JMP

TIPRANKS
·
Nov 11

Spruce Biosciences Q3 net loss narrows

Reuters
·
Nov 11

Spruce Biosciences reports Q3 EPS (14.58) vs. ($15.75) last year

TIPRANKS
·
Nov 11

Spruce Biosciences Raises $50 Million in Private Placement

Reuters
·
Nov 11

Spruce Biosciences Completes One-for-75 Reverse Stock Split

Reuters
·
Nov 11

Spruce Biosciences Inc expected to post a loss of $13.93 a share - Earnings Preview

Reuters
·
Nov 08

Spruce Biosciences files to sell 735K shares of common stock for holders

TIPRANKS
·
Oct 30

Spruce Biosciences Inc - May Offer up to $300 Mln in Securities - SEC Filing

THOMSON REUTERS
·
Oct 30

Spruce Biosciences upgraded to Outperform from Market Perform at Citizens JMP

TIPRANKS
·
Oct 28

Spruce Biosciences Is Maintained at Market Perform by Leerink Partners

Dow Jones
·
Oct 22

Spruce Biosciences price target raised to $160 from $10 at Leerink

TIPRANKS
·
Oct 22

Spruce Biosciences Board Member Resigns

TIPRANKS
·
Oct 18

Spruce Biosciences Director Bali Muralidhar Resigns

Reuters
·
Oct 18

Kenneth Griffin Reports 9.99% Passive Stake in Spruce Biosciences Inc as of Oct 9 - SEC Filing

THOMSON REUTERS
·
Oct 17

Spruce Biosciences Inc. Files Initial Beneficial Ownership Statement for Parkman Healthcare Partners LLC

Reuters
·
Oct 16

Spruce Biosciences Stock Extends 2,900% Rally after FDA Breakthrough Therapy Designation Ignites Investor Frenzy

TIPRANKS
·
Oct 09

Spruce Biosciences Files Initial Beneficial Ownership Statement Listing Parkman Healthcare Partners LLC as 10% Owner

Reuters
·
Oct 09

Spruce Biosciences Secures $50 Million Investment Deal

TIPRANKS
·
Oct 09